Navigation Links
Vitamin A derivative associated with reduced growth in some lung cells
Date:10/30/2007

Treatment with a derivative of vitamin A called retinoic acid was associated with reduced lung cell growth in a group of former heavy smokers, according to a study published online October 30 in the Journal of the National Cancer Institute.

Former smokers remain at elevated risk for lung cancer. According to one hypothesis, lung cells that were damaged during years of smoking may continue to grow and evolve into cancer even after that person has quit smoking. Previous studies have suggested that retinoids, a class of drugs related to vitamin A, may be effective for preventing lung cancer in former smokers. Retinoids have also been shown to slow the growth of cancer cells in laboratory experiments.

Investigators at the University of Texas M.D. Anderson Cancer Center in Houston previously conducted a double-blind lung cancer prevention trial among 225 former heavy smokers. The subjects were randomly assigned to receive a 3-month treatment of 13-cis-retinoic acid and vitamin E, or 9-cis-retinoic acid, or a placebo. Walter Hittelman, Ph.D., and colleagues later examined biopsy samples of participants lung tissue taken before and after treatment, then measured the proliferation of the cells using a biomarker called Ki-67.

Both treatments reduced cell proliferation in one layer of the lung cells (the parabasal layer), but not the other (the basal layer), which surprised the researchers.

In patients given 13-cis-retinoic acid and vitamin E, there was a statistically significant reduction in parabasal layer cell growth compared with the placebo treatment, but not in those given 9-cis-retinoic acid. When the data were analyzed by the biopsy site, both treatments statistically significantly reduced cell growth.

It will therefore be important to distinguish the effects of molecularly targeted agents on the basal and parabasal [lung cell] layers in proposed lung chemoprevention trials with long follow-up, the authors write.

In an accompanying editorial, Eva Szabo, M.D., of the National Cancer Institute in Bethesda, Md., discusses the appropriateness of using the biomarker Ki-67 as an alternative endpoint in cancer prevention trials. While the biomarker showed that the retinoid agents were able to reduce cell growth, she says it is still too soon to test them in more advanced clinical trials. We do not have a full understanding of the effects of these agents on [lung cells] or their effects during the full spectrum of carcinogenesis, she writes.


'/>"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. Vitamin B12 can help in detecting cancers
2. Vitamins-The answer to Heart Disease?
3. Vitamin E, the latest warrior against diabetes
4. Vitamin Shields Brittle Bones
5. Beer vitamin protects heart
6. B Vitamin protects and lowers toxicity of Arthritis Drug
7. B Vitamin Supplementatoin Saves Money and Lives
8. Eat Vitamin C and stay young
9. Taking Vitamin Supplements With Caution
10. Vitamin C reverses pre eclampsia
11. Bony Vitamin D a boon for lungs too
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... 17, 2017 , ... Mirror Mirror Beauty Boutique, Houston’s premiere CoolSculpting provider ... in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD FACS, is delighted that ... , Produced by Zeltiq, CoolSculpting is approved by the Food and Drug Administration ...
(Date:1/17/2017)... ... 2017 , ... SensorInsight ®, an Internet of Things ... U.S.A. to offer Internet of Things (IoT) solutions based on Libelium ... such as monitoring solutions used to detect potentially hazardous conditions in urban areas, ...
(Date:1/17/2017)... Mass. (PRWEB) , ... January 17, 2017 , ... ... company to visualize, detect, and eliminate cyber threats in real-time, today announced a ... Solutions provider, headquartered in Selangor, Malaysia. Joining other Seceon partners, TechLab Security has ...
(Date:1/17/2017)... ... January 17, 2017 , ... Today, FloSports , ... announced a new agreement as part of a long-term extension of their media ... includes the airing of some of the sport’s premier events exclusively on FloWrestling.com as ...
(Date:1/16/2017)... ... January 16, 2017 , ... Gym Source, America’s leading retailer of premium residential ... Hanover, New Jersey. , “We are elated to be opening this new showroom,” explains ... designed to give clients a seamless and motivating shopping experience.” , Every fitness journey ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... SCOTTSDALE, Ariz. , Jan. 17, 2017 ... retired US Navy Capt. Mark Kelly as ... (ACMA) 2017 National Conference in Washington D.C. ... shuttle commander, will speak on Friday morning, April 21 ... management professionals from across the country are expected to ...
(Date:1/17/2017)... Jan. 17, 2017  Market Research Future published a Half Cooked ... is expected to reach USD 33.6 million during the period 2016 ... Highlights ... Endoscopy Devices Market has been examined as a swiftly growing market ... huge demand for endoscopy device in various regions.  The increasing growth ...
(Date:1/17/2017)... NEW YORK , Jan. 17, 2016  Attorney Advertising ... on behalf of purchasers of Anthera Pharmaceuticals, Inc. ("Anthera" or ... encouraged to obtain additional information and assist the investigation by ... investigation concerns whether Anthera and certain of its officers and/or ... Exchange Act of 1934. ...
Breaking Medicine Technology: